Scottish Medicines Consortium Evaluation Programme December 2012

Marion Bennie; Emma Dunlop Corcoran; James W. Dear; Sharon Hems; S. McTaggart; Rosemary Newham; Vicky Norris; Craig Waugh

Scottish Medicines Consortium Evaluation Programme December 2012

Marion Bennie, Emma Dunlop Corcoran, James W. Dear, Sharon Hems, S. McTaggart, Rosemary Newham, Vicky Norris, Craig Waugh

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Book/Report › Commissioned report

Abstract

The Scottish Medicines Consortium (SMC) provides advice to the National Health Service (NHS) in Scotland about the comparative clinical and cost-effectiveness of all newly licensed medicines, new formulations of existing medicines and new indications for established products. SMC advice is conveyed to prescribers th rough the Detailed Advice Document (DAD), which is available on the SMC website and is disseminated to Area Drug and Therapeutics Committees (ADTCs) across Scotland. Since 2005, SMC has also provided a horizon scanning function and, through the Forward Look report, provides early intelligence to NHS Scotland on new medicines in development.

Original language	English
Publisher	University of Strathclyde
Commissioning body	Healthcare Improvement Scotlad
Number of pages	61
Publication status	Unpublished - 2012

Keywords

Scottish Medicines Consortium
National Health Service
NHS Scotland
detailed advice document

Cite this

@book{37a17498f8fb4818a81c5a37c5c23ea9,

title = "Scottish Medicines Consortium Evaluation Programme December 2012",

abstract = "The Scottish Medicines Consortium (SMC) provides advice to the National Health Service (NHS) in Scotland about the comparative clinical and cost-effectiveness of all newly licensed medicines, new formulations of existing medicines and new indications for established products. SMC advice is conveyed to prescribers th rough the Detailed Advice Document (DAD), which is available on the SMC website and is disseminated to Area Drug and Therapeutics Committees (ADTCs) across Scotland. Since 2005, SMC has also provided a horizon scanning function and, through the Forward Look report, provides early intelligence to NHS Scotland on new medicines in development. ",

keywords = "Scottish Medicines Consortium, National Health Service, NHS Scotland, detailed advice document",

author = "Marion Bennie and Corcoran, {Emma Dunlop} and Dear, {James W.} and Sharon Hems and S. McTaggart and Rosemary Newham and Vicky Norris and Craig Waugh",

year = "2012",

language = "English",

publisher = "University of Strathclyde",

}

TY - BOOK

T1 - Scottish Medicines Consortium Evaluation Programme December 2012

AU - Bennie, Marion

AU - Corcoran, Emma Dunlop

AU - Dear, James W.

AU - Hems, Sharon

AU - McTaggart, S.

AU - Newham, Rosemary

AU - Norris, Vicky

AU - Waugh, Craig

PY - 2012

Y1 - 2012

N2 - The Scottish Medicines Consortium (SMC) provides advice to the National Health Service (NHS) in Scotland about the comparative clinical and cost-effectiveness of all newly licensed medicines, new formulations of existing medicines and new indications for established products. SMC advice is conveyed to prescribers th rough the Detailed Advice Document (DAD), which is available on the SMC website and is disseminated to Area Drug and Therapeutics Committees (ADTCs) across Scotland. Since 2005, SMC has also provided a horizon scanning function and, through the Forward Look report, provides early intelligence to NHS Scotland on new medicines in development.

AB - The Scottish Medicines Consortium (SMC) provides advice to the National Health Service (NHS) in Scotland about the comparative clinical and cost-effectiveness of all newly licensed medicines, new formulations of existing medicines and new indications for established products. SMC advice is conveyed to prescribers th rough the Detailed Advice Document (DAD), which is available on the SMC website and is disseminated to Area Drug and Therapeutics Committees (ADTCs) across Scotland. Since 2005, SMC has also provided a horizon scanning function and, through the Forward Look report, provides early intelligence to NHS Scotland on new medicines in development.

KW - Scottish Medicines Consortium

KW - National Health Service

KW - NHS Scotland

KW - detailed advice document

M3 - Commissioned report

BT - Scottish Medicines Consortium Evaluation Programme December 2012

PB - University of Strathclyde

ER -